Caricamento...

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Wolfson, Eya, Goldenberg, Maria, Solomon, Shira, Frishberg, Amit, Pinkas-Kramarski, Ronit
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5323158/
https://ncbi.nlm.nih.gov/pubmed/27542246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11323
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !